研究者
J-GLOBAL ID：202101020528490551   更新日: 2021年07月20日

鹿原 真樹

KABARA Maki
競争的資金等の研究課題 (2件)：
  • 2017 - 2022 周細胞の多分化能を制御する新規因子の機能解析
  • 2015 - 2017 血管新生における新規因子Ninjurin1の機能解明
論文 (25件)：
  • Kiwamu Horiuchi, Kohei Kano, Akiho Minoshima, Taiki Hayasaka, Atsushi Yamauchi, Takamitsu Tatsukawa, Risa Matsuo, Yuri Yoshida, Yui Tomita, Maki Kabara, et al. Pericyte-specific deletion of Ninjurin-1 induces fragile vasa vasorum formation and enhances intimal hyperplasia of injured vasculature. American journal of physiology. Heart and circulatory physiology. 2021
  • Kohei Kano, Kiwamu Horiuchi, Yuri Yoshida, Taiki Hayasaka, Maki Kabara, Yui Tomita, Takamitsu Tatsukawa, Risa Matsuo, Jun Sawada, Naoki Nakagawa, et al. EphA7+ perivascular cells as myogenic and angiogenic precursors improving skeletal muscle regeneration in a muscular dystrophic mouse model. Stem cell research. 2020. 47. 101914-101914
  • Yuri Yoshida, Maki Kabara, Kohei Kano, Kiwamu Horiuchi, Taiki Hayasaka, Yui Tomita, Naofumi Takehara, Akiho Minoshima, Tatsuya Aonuma, Keisuke Maruyama, et al. Capillary-resident EphA7+ pericytes are multipotent cells with anti-ischemic effects through capillary formation. Stem cells translational medicine. 2020. 9. 1. 120-130
  • Keisuke Maruyama, Naoki Nakagawa, Ayana Suzuki, Maki Kabara, Motoki Matsuki, Motohiro Shindo, Sari Iwasaki, Yayoi Ogawa, Naoyuki Hasebe. Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019. 74. 6. 844-848
  • Yui Tomita, Kiwamu Horiuchi, Kohei Kano, Takamitsu Tatsukawa, Risa Matsuo, Taiki Hayasaka, Yuri Yoshida, Maki Kabara, Satoshi Yasuda, Keiichi Nakajima, et al. Ninjurin 1 mediates peripheral nerve regeneration through Schwann cell maturation of NG2-positive cells. Biochemical and biophysical research communications. 2019. 519. 3. 462-468
もっと見る
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM